Literature DB >> 10837193

IgG subclass distribution of hepatitis B surface antigen antibodies induced in children with chronic hepatitis B infection after interferon-alpha therapy.

H Gregorek1, K Madaliński, M Woynarowski, J Mikolajewicz, M Syczewska, J Socha.   

Abstract

The IgG subclass distribution of antibody to hepatitis B surface antigen (anti-HBs) was investigated in 19 children with chronic active hepatitis B infection who showed a complete serological seroconversion after interferon-alpha therapy. Determinations were done 6 and 12 months after treatment. Our results showed no selectivity in anti-HBs synthesis among IgG subclasses. All 4 IgG isotypes were involved in the response, with similar percentage contributions, on average, of IgG1 (35%), IgG3 (27%), and IgG4 (28%), followed by IgG2 (10%). IgG4 became the second most dominant isotype at the end of observation. These results are in contrast to those found after natural seroconversion, in which anti-HBs was highly restricted to neutralizing IgG1 and IgG3, with only a minor contribution from IgG2 and IgG4. It is postulated that analysis of the specific profiles of IgG subclasses may be of value for the estimation of the therapeutic efficacy of recombinant interferon-alpha used and may be helpful in choosing more-effective treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837193     DOI: 10.1086/315515

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  4 in total

1.  Immunoglobulin G subclass profile of antimeasles response in vaccinated children and in adults with measles history.

Authors:  Anna P Toptygina; Alexander L Pukhalsky; Vladimir A Alioshkin
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

2.  EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function.

Authors:  K Bickham; C Münz; M L Tsang; M Larsson; J F Fonteneau; N Bhardwaj; R Steinman
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

3.  Induction of IgA and sustained deficiency of cell proliferative response in chronic hepatitis C.

Authors:  Yalena Amador-Cañizares; Liz Alvarez-Lajonchere; Ivis Guerra; Ingrid Rodríguez-Alonso; Gillian Martínez-Donato; Julián Triana; Eddy E González-Horta; Angel Pérez; Santiago Dueñas-Carrera
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

Review 4.  Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies.

Authors:  Juan C Almagro; Gabriela Mellado-Sánchez; Martha Pedraza-Escalona; Sonia M Pérez-Tapia
Journal:  Int J Mol Sci       Date:  2022-08-28       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.